CompletedNot Applicable

BEAST: A Pilot Trial

United States15 participantsStarted 2022-09-01

Plain-language summary

This pilot study trial will test the acceptability, feasibility, and usability of a brief enhanced anxiety sensitivity treatment to reduce anxiety sensitivity and functional impairment in Veterans.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Are English-speaking * Score equal to or greater than 9 on the SSASI indicating elevated anxiety sensitivity * Score equal to or greater than 5 on the WHODAS 2.0 Exclusion Criteria: * Veterans with cognitive impairment as measured scoring equal to or greater than 11 on the Blessed * Orientation-Memory-Concentration Test * Veterans without access to a smartphone * Veterans with significant medical or psychiatric conditions that may limit participation, including: * severe documented schizophrenia * an ongoing active psychotic or manic state * an imminent suicide crisis will be excluded from our study and provided the appropriate referral

What they're measuring

Mean Change in Anxiety Sensitivity

Timeframe: From baseline to post-intervention (two-weeks after virtual treatment session)

Program Satisfaction

Timeframe: Post-intervention (two weeks after virtual treatment session)

Mean Change in Functional Impairment

Timeframe: From baseline to post-intervention (two-weeks after virtual treatment session)

Trial details

NCT IDNCT05416203

SponsorVA Office of Research and Development

Sponsor typeFED

Study typeINTERVENTIONAL

Primary completion2024-05-31

Results submitted2025-05-22

View on ClinicalTrials.gov More Anxiety Sensitivity trials